Brown Advisory Inc ownership in 2X7 / OrthoPediatrics Corp.

OrthoPediatrics Corp.

DE ˙ DB ˙ US68752L1008

15,50 € ↑1,50 (10,71%)

2026-06-05
PREZZO DELLE AZIONI

Security	DE:2X7 / OrthoPediatrics Corp.
Institution	Brown Advisory Inc
Latest Disclosed Ownership	1,621,102 shares
Ownership	6.90%

2024-02-09 - Brown Advisory Inc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,621,102 shares of OrthoPediatrics Corp. (DE:2X7). This represents 6.9 percent ownership of the company. In their previous filing dated 2023-02-09 , Brown Advisory Inc had reported owning 1,583,702 shares, indicating an increase of 2.36 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2024-02-09	2024-02-09	13G/A	1,583,702	1,621,102	2.36	6.90	0.00
2023-02-09	2023-02-09	13G/A	1,096,524	1,583,702	44.43	6.90	23.88
2022-02-07	2022-02-07	13G/A	1,132,389	1,096,524	-3.17	5.57	-3.80
2021-02-08	2021-02-08	13G	1,132,389	1,132,389	0.00	5.79	0.00
2021-02-08	2021-02-08	13G	1,132,389	1,132,389	0.00	5.79	0.00

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-15	2026-03-31	13F	ORTHOPEDIATRICS	COM	68752L100	1,518,018	-372,868	-19.72	24,091	-28.27	0.0176
2026-02-13	2025-12-31	13F	ORTHOPEDIATRICS	COM	68752L100	1,890,886	-3,819	-0.20	33,582	-4.35	0.0469
2025-11-14	2025-09-30	13F	ORTHOPEDIATRICS	COM	68752L100	1,894,705	270,004	16.62	35,109	0.60	0.0457
2025-08-13	2025-06-30	13F	ORTHOPEDIATRICS	COM	68752L100	1,624,701	-4,046	-0.25	34,899	-13.01	0.0459
2025-04-30	2025-03-31	13F	ORTHOPEDIATRICS	COM	68752L100	1,628,747	94,719	6.17	40,116	12.82	0.0573
2025-02-14	2024-12-31	13F	ORTHOPEDIATRICS	COM	68752L100	1,534,028	-63,375	-3.97	35,559	-17.89	0.0451
2024-11-13	2024-09-30	13F	ORTHOPEDIATRICS	COM	68752L100	1,597,403	-19,443	-1.20	43,306	-6.87	0.0544
2024-08-14	2024-06-30	13F	ORTHOPEDIATRICS	COM	68752L100	1,616,846	-31,592	-1.92	46,500	-3.26	0.0608
2024-04-24	2024-03-31	13F	ORTHOPEDIATRICS	COM	68752L100	1,648,438	19,659	1.21	48,068	-9.22	0.0643
2024-02-08	2023-12-31	13F	ORTHOPEDIATRICS	COM	68752L100	1,628,779	25,337	1.58	52,952	3.20	0.0744
2023-10-25	2023-09-30	13F	ORTHOPEDIATRICS	COM	68752L100	1,603,442	-1,331	-0.08	51,310	-27.08	0.0842
2023-07-31	2023-06-30	13F	ORTHOPEDIATRICS	COM	68752L100	1,604,773	-7,749	-0.48	70,369	-1.47	0.1099
2023-05-08	2023-03-31	13F	ORTHOPEDIATRICS	COM	68752L100	1,612,522	26,668	1.68	71,419	13.35	0.1209
2023-02-13	2022-12-31	13F	ORTHOPEDIATRICS	COM	68752L100	1,585,854	18,238	1.16	63,006	-12.89	0.1170
2022-11-14	2022-09-30	13F	ORTHOPEDIATRICS	COM	68752L100	1,567,616	7,059	0.45	72,329	7.41	0.1407
2022-11-14	2022-06-30	13F/A-2	ORTHOPEDIATRICS	COM	68752L100	1,560,557	316,487	25.44	67,338	0.25	0.1266
2022-09-13	2022-06-30	13F/A-1	ORTHOPEDIATRICS	COM	68752L100	1,505,761	304,380		64,973		0.1124
2022-08-02	2022-06-30	13F	ORTHOPEDIATRICS	COM	68752L100	1,503,287	302,186		64,961		0.0432
2022-11-14	2022-03-31	13F/A-2	ORTHOPEDIATRICS	COM	68752L100	1,244,070	175,506	16.42	67,167	5.01	0.1001
2022-09-13	2022-03-31	13F/A-1	ORTHOPEDIATRICS	COM	68752L100	1,201,381	132,817		64,863		0.0911
2022-05-09	2022-03-31	13F	ORTHOPEDIATRICS	COM	68752L100	1,201,101	132,537		64,881		0.0882
2022-01-27	2021-12-31	13F	ORTHOPEDIATRICS	COM	68752L100	1,068,564	-4,171	-0.39	63,964	-8.98	0.0793
2021-11-12	2021-09-30	13F	ORTHOPEDIATRICS	COM	68752L100	1,072,735	-194,635	-15.36	70,275	-12.24	0.1037
2021-07-29	2021-06-30	13F	ORTHOPEDIATRICS	COM	68752L100	1,267,370	111,604	9.66	80,072	42.12	0.1207
2021-05-14	2021-03-31	13F	ORTHOPEDIATRICS	COM	68752L100	1,155,766	26,987	2.39	56,343	21.01	0.0963
2021-02-12	2020-12-31	13F	ORTHOPEDIATRICS	COM	68752L100	1,128,779	17,794	1.60	46,562	-8.73	0.0826
2020-11-16	2020-09-30	13F	ORTHOPEDIATRICS	COM	68752L100	1,110,985	199,641	21.91	51,018	27.93	0.1054
2020-08-14	2020-06-30	13F	ORTHOPEDIATRICS	COM	68752L100	911,344	257,050	39.29	39,881	53.76	0.0929
2020-05-15	2020-03-31	13F	ORTHOPEDIATRICS	COM	68752L100	654,294	483,925	284.05	25,937	224.01	0.0795
2020-02-14	2019-12-31	13F	ORTHOPEDIATRICS	COM	68752L100	170,369	72,186	73.52	8,005	131.16	0.0203
2019-11-14	2019-09-30	13F	ORTHOPEDIATRICS	COM	68752L100	98,183	98,183		3,463		0.0097
2019-08-12	2019-06-30	13F	ORTHOPEDIATRICS	COM	68752L100	0	-4,556	-100.00	0	-100.00
2019-05-15	2019-03-31	13F	ORTHOPEDIATRICS	COM	68752L100	4,556	4,556		202		0.0006

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.